Giant cell formation: The way to cell death or cell survival?

Central European Journal of Biology

Volumn 6, Issue 5, 2011, Pages 675-684

  Horbay, Rostyslav ^a   Stoika, Rostyslav ^a,b  

^a IVAN FRANKO NATIONAL UNIVERSITY OF LVIV   (Ukraine)

^b INSTITUTE OF CELL BIOLOGY   (Ukraine)

Author keywords

tubulin; Apoptosis; Giant cells; Mitotic catastrophe; Neosis; NK Ly lymphoma; Paclitaxel; Vinblastine

Indexed keywords

EID: 80052282707     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-011-0058-0     Document Type: Review

References (72)

1. Mansilla S., Priebe W., Portugal J., Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms, Cell Cycle, 2006, 5, 53-60.
2. Wheatley D., Regrowth of Tumour Cells from Supposedly Terminal Giant Cells, Oncology News, 2006, 1, 3.
3. Wheatley D., Growing evidence of the repopulation of regressed tumours by the division of giant cells, Cell Biol. Int., 2008, 32, 1029-1030.
4. Hall L. L., Th'ng J. P., Guo X. W., Teplitz R. L., Bradbury E. M., A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation, Cancer Res, 1996, 56, 3551-3559.
5. Rajaraman R., Guernsey D. L., Rajaraman M. M., Rajaraman S. R., Stem cells, senescence, neosis and self-renewal in cancer, Cancer Cell Int., 2006, 6, 1-25.
6. Brodsky V. Y., Uryvaeva I. V., Genome Multiplication in Growth and Development. Biology of Polyploid and Polytene Cells., Cambridge Univ. Press, New York, 1985.
7. Panchuk R. R., Boiko N. M., Lootsik M. D., Stoika R. S., Changes in signaling pathways of cell proliferation and apoptosis during NK/Ly lymphoma aging, Cell Biol. Int., 2008, 32, 1057-1063.
8. Vakifahmetoglu H., Olsson M., Zhivotovsky B., Death through a tragedy: mitotic catastrophe, Cell Death Differ., 2008, 15, 1153-1162.
9. Radford I. R., Murphy T. K., Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage, Int. J. Radiat. Biol., 1994, 65, 229-239.
10. Rajaraman R., Guernsey D. L., Rajaraman M. M., Rajaraman S. R., Neosis - a parasexual somatic reduction division in cancer, Int. J. Hum. Genet., 2007, 7, 29-48.
11. Erenpreisa J. A., Cragg M. S., Mitotic death: a mechanism of survival? A review, Cancer Cell Int., 2001, 1, 1-7.
12. Tolmach L. J., Marcus P. L. Development of X-ray induced giant HeLa cells, Expl Cell Res., 1960, 20, 350-360.
13. Nitta M., Kobayashi O., Honda S., Hirota T., Kuninaka S., Marumoto T., et al., Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents, Oncogene, 2004, 23, 6548-6558.
14. Illidge T. M., Cragg M. S., Fringes B., Olive P., Erenpreisa J. A., Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage, Cell Biol. Int., 2000, 24, 621-633.
15. Castedo M., Perfettini J. L., Roumier T., Andreau K., Medema R., Kroemer G., Cell death by mitotic catastrophe: a molecular definition, Oncogene, 2004, 23, 2825-2837.
16. Chu K., Teele N., Dewey M. W., Albright N., Dewey W. C., Computerized video time lapse study of cell cycle delay and arrest, mitotic catastrophe, apoptosis and clonogenic survival in irradiated 14-3-3sigma and CDKN1A (p21) knockout cell lines, Radiat. Res., 2004, 162, 270-286.
17. Tauchi H., Sawada S., Analysis of mitotic cell death caused by radiation in mouse leukaemia L5178Y cells: apoptosis is the ultimate form of cell death following mitotic failure, Int. J. Radiat. Biol., 1994, 65, 449-455.
18. Waldman T., Lengauer C., Kinzler K. W., Vogelstein B., Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21, Nature, 1996, 381, 713-716.
19. Wagner M., Hampel B., Bernhard D., Hala M., Zwerschke W., Jansen-Dürr P., Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis, Exp. Gerontol., 2001, 381, 1327-1347.
20. Hartwell L. H., Kastan M. B., Cell cycle control and cancer, Science, 1994, 266, 1821-1828.
21. Ianzini F., Mackay M. A., Delayed DNA-damage associated with mitotic catastrophe following X-irradiation of HeLa S3 cells, Mutagenesis, 1998, 13, 337-344.
22. McIntosh J. R., Cell biology. Microtubule catastrophe, Nature, 1984, 312, 196-197.
23. Glucksmann A., Spear F. G., The effect of gammaradiation on cells in vivo. Part III, Br. J. Radiol., 1941, 14, 65-77.
24. Mansilla S., Bataller M., Portugal J., Mitotic catastrophe as a concequence of chemotherapy, Anticancer Agents Med. Chem., 2006, 6, 589-602.
25. Roninson I. B., Broude E. V., Chang B. D., If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells, Drug Resist. Updat., 2001, 4, 303-313.
26. Mackey M. A., Morgan W. F., Dewey W. C., Nuclear fragmentation and premature chromosome condensation induced by heat shock in S-phase Chinese hamster ovary cells, Cancer Res., 1988, 48, 6478-6483.
27. Johnson R. T., Rao P. N., Hughes H. D., Mammalian cell fusion. 3. A HeLa cell inducer of premature chromosome condensation active in cells from a variety of animal species, J. Cell Physiol., 1970, 76, 151-157.
28. Swanson P. E., Carroll S. B., Zhang X. F., Mackey M. A., Spontaneous premature chromosome condensation, micronucleus formation, and nonapoptotic cell death in heated HeLa S3 cells, Ultrastructural observations, Am. J. Pathol., 1995, 146, 963-971.
29. Castedo M., Kroemer G., Mitotic catastrophe: a special case of apoptosis, J. Soc. Biol., 2004, 198, 97-103.
30. Castedo M., Perfettini J. L., Roumier T., Valent A., Raslova H., Yakushijin K., et al., Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy, Oncogene, 2004, 23, 4362-4370.
31. Kastan M. B., Bartek J., Cell-cycle checkpoints and cancer, Nature, 2004, 432, 316-323.
32. Schimming R., Mason K. A., Hunter N., Weil M., Kishi K., Milas L., Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel, Cancer Chemother. Pharmacol., 1999, 43, 165-172.
33. Puig P-E., Guilly M-N., Bouchot A., Droin N., Cathelin D., Bouyer F., et al., Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy, Cell Biol. Int., 2008, 32, 1031-1043.
34. Zhou J., Giannakakou P., Targeting Microtubules for Cancer Chemotherapy, Curr. Med. Chem. - Anti-Cancer Agents, 2005, 5, 65-71.
35. Heald R., Nogales E., Microtubule dynamics, J. Cell Sci., 2002, 115, 3-4.
36. Dutcher S. K., The tubulin fraternity: alpha to eta, Curr. Opin. Cell Biol., 2001, 13, 49-54.
37. Goodman J., Walsh V., The Story of Taxol: Nature and Politics in the Pursuit of an Anti-Cancer Drug, Cambridge Univ. Press, 2001.
38. Ganguly A., Yang H., Cabral F., Paclitaxeldependent cell lines reveal a novel drug activity, Mol. Cancer Ther. 2010, 9, 2914-2923.
39. Okouneva T., Hill B. T., Wilson L., Jordan M. A., The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics, Mol. Cancer Ther., 2003, 2, 427-436.
40. Jordan M. A., Wendell K., Gardiner S., Derry W. B., Copp H., Wilson L., Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death, Cancer Res., 1996, 56, 816-825.
41. Jordan M. A., Wilson L., Microtubules as a target for anticancer drugs, Nature Rev. Cancer, 2004, 4, 253-265.
42. Arisan E. D., Kutuk O., Tezil T., Bodur C., Telci D., Basaga H., Small inhibitor of Bcl-2, HA14- 1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells, Breast Cancer Res. Treat, 2009, 119, 271-281.
43. Gascoine K. E., Taylor S. S., How do anti-mitotic drugs kill cancer cells?, J. Cell Sci., 2009, 122, 2579-2585.
44. Sundaram M., Guerrnsey D. L., Rajaraman M. M., Rajaraman R. R., Neosis: a novel type of cell division in cancer, Cancer Biol. Ther., 2004, 3, 207-208.
45. Cui Q., Harvey A. R., At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats, J. Neurosci., 1995, 15, 8143-8155.
46. Morgan D. O., The Cell Cycle: Principles of Control, 1st Ed., New Science Press, London, 2007.
47. Schulz L. C., Widmaier E. P., Qiu J., Roberts R. M., Effect of Leptin on Mouse Trophoblast Giant Cells, Biol. Reprod., 2009, 80, 415-424.
48. Erenpreisa J., Ivanov A., Wheatley S. P., Kosmacek E. A., Ianzini F., Anisimov A. P., et al., Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase, Cell Biol. Int., 2008, 32, 1044-1056.
49. Ullah Z., Lee C. Y., DePamphilis M. L., Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy, Cell Division, 2009, 4, 1-15.
50. Lee J. H., Paull T. T., Activation and regulation of ATM kinase activity in response to DNA doublestrand breaks., Oncogene, 2007, 26, 7741-7748.
51. Cimprich K. A., Shin T. B., Keith C. T., Schreiber S. L., cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein, Proc. Natl. Acad. Sci. USA, 1996, 93, 2850-2855.
52. Kim S. T., Lim D. S., Canman C. E., Kastan M. B., Substrate specificities and identification of putative substrates of ATM kinase family members, J. Biol. Chem., 1999, 274, 37538-37543.
53. Russell P., Checkpoints on the road to mitosis, Trends Biochem. Sci., 1998, 23, 399-402.
54. Shieh S. Y., Ahn J., Tamai K., Taya Y., Prives C., The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites, Genes, 2000, 14, 289-300.
55. Gartel A. L., Radhakrishnan S. K., Lost in transcription: p21 repression, mechanisms, and consequences, Cancer Res., 2005, 65, 3980-3985.
56. Nurse P., Universal control mechanism regulating onset of M-phase, Nature, 1990, 344, 503-508.
57. Peng C. Y., Graves P. R., Thoma R. S., Wu Z., Shaw A. S., Piwnica-Worms H., Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on Serine 216, Science, 1997, 277, 1501-1505.
58. Maltzman W., Czyzyk L., UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells, Mol. Cell Biol., 1984, 4, 1689-1694.
59. Agarwal M. L., Agarwal A., Taylor W. R., Stark G. R., p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts, Proc. Natl. Acad. Sci. USA, 1995, 92, 8493-8497.
60. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W., Participation of p53 protein in the cellular response to DNA damage, Cancer Res., 1991, 51, 6304-6307.
61. Medema R. H., Klompmaker R., Smits V. A., Rijksen G., p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNAreplication or stress-activated kinases, Oncogene, 1998, 16, 431-441.
62. Greenblatt M. S., Bennett W. P., Hollstein M., Harris C. C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 1994, 54, 4855-4878.
63. Tsai K. Y., Hu Y., Macleod K. F., Crowley D., Yamasaki L., Jacks T., Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos, Mol. Cell., 1998, 2, 293-304.
64. Erenpreisa J. A., Cragg M. S., Fringes B., Sharakhov I., Illidge T. M., Release of mitotic descendents by giant cells by giant cells from Burkitt's lymphoma cell line, Cell Biol. Int., 2000, 24, 635-648.
65. Navolanic P. M., Akula S. M., McCubrey J. A., Neosis and its potential role in cancer development and chemoresistance, Cancer Biol. Ther., 2004, 3, 219-220.
66. Mackey M. A., Morgan W. F., Dewey W. C., Nuclear fragmentation and premature chromosome condensation induced by heat shock in S-phase Chinese hamster ovary cells, Cancer Res., 1988, 48, 6478-6483.
67. Lowe S. W., Bodis S., McClatchey A., Remington L., Ruley H. E., Fisher D. E., et al., p53 status and the efficacy of cancer-therapy in-vivo, Science, 1994, 266, 807-810.
68. Olive P. L., Banath J. P., Durand R. E., Development of apoptosis and polypl-oidy in human lymphoblast cells as a function of the cell cycle at the time of irradiation, Radiation Res., 1996, 146, 595-602.
69. Erenpreisa J., Salmina K., Huna A., Kosmacek E. A., Cragg M., Ianzini F., et al., Polyploid tumour cells elicit para-diploid progeny through depolyploidising divisions and regulated autophagic degradation, Cell Biol. Int., 2011, 35, 687-695.
70. R. Rajaraman, The Origin of Tumor Cell Heterogeneity, The IUP Journal of Biotechnology, 2010, 4, 1-39.
71. Haldar S., Jena N., Croce C. M., Inactivation by Bcl-2 by phosphorylation, Proc. Natl. Acad. Sci. USA, 1995, 92, 4507-4511.
72. Wang L. G., Kreis W., Budman D. R., The effect of antimicrotubule agent on signal transduction pathway of apoptosis: a review, Cancer Chemother. Pharmacol., 1999, 44, 355-361.